PAVBLU
- Product NDC
- 55513-056
- 11-digit product format
- 555130056
- Labeler code
- 55513
- Product ID
- 55513-056_1c5a6878-6bc7-47c3-8d97-39c466cbab1c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aflibercept-ayyh
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Amgen, Inc
- Application
- BLA761298
- Marketing category
- BLA
- Marketing start
- 2024-10-28
- Substance
- AFLIBERCEPT
- Active strength
- 2 mg/.05mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PAVBLU
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AFLIBERCEPT | 2 mg/.05mL |
Harmonized UNII identifiers#
UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 15C2VL427D | Internal UNII lookup |
Harmonized RxCUI identifiers#
RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 2696260 | Internal RxNorm lookup |
| 2696267 | Internal RxNorm lookup |
| 2696270 | Internal RxNorm lookup |
| 2696274 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55513-056-01 | PAVBLU | 0.05 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.05 | | 9 |
| 55513-056-01 | PAVBLU | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 9 |
| 55513-056-96 | PAVBLU | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 9 |
| 55513-056-96 | PAVBLU | 0.05 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.05 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55513-056 | PAVBLU (AFLIBERCEPT-AYYH) INJECTION, SOLUTION [AMGEN, INC] | 6 | Current NDC, 4 package rows | 20250309_c61062f3-80ec-4a20-8c28-46e468592a06.zip |
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761298 | Pavblu | aflibercept-ayyh | 351(k) Interchangeable | Rx | 2026-10-01 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 55513-056-01 | 55513005601 | 1 SYRINGE in 1 CARTON (55513-056-01) / .05 mL in 1 SYRINGE | 1 syringe | 2024-10-28 | No | No | Current |
| 55513-056-96 | 55513005696 | 1 SYRINGE in 1 CARTON (55513-056-96) / .05 mL in 1 SYRINGE | 1 syringe | 2024-10-28 | No | No | Current |